Nifty 16912.25 (-1.65%)
Sensex 56747.14 (-1.65%)
Nifty Bank 35735.9 (-1.27%)
Nifty IT 34879.4 (-2.70%)
Nifty Financial Services 17596.7 (-1.03%)
Adani Ports 723.45 (-1.90%)
Asian Paints 3038.30 (-2.32%)
Axis Bank 663.10 (-1.47%)
B P C L 383.45 (-0.63%)
Bajaj Auto 3249.75 (-1.16%)
Bajaj Finance 6951.75 (-1.66%)
Bajaj Finserv 16893.45 (-3.40%)
Bharti Airtel 697.60 (-2.89%)
Britannia Inds. 3496.20 (-1.62%)
Cipla 894.95 (-1.87%)
Coal India 148.55 (-7.01%)
Divis Lab. 4646.80 (-2.32%)
Dr Reddys Labs 4498.70 (-2.13%)
Eicher Motors 2444.10 (-0.47%)
Grasim Inds 1660.75 (-2.53%)
H D F C 2768.80 (-0.10%)
HCL Technologies 1136.55 (-2.98%)
HDFC Bank 1503.80 (-0.64%)
HDFC Life Insur. 684.20 (-0.98%)
Hero Motocorp 2420.00 (-1.72%)
Hind. Unilever 2306.50 (-1.59%)
Hindalco Inds. 421.35 (-0.78%)
I O C L 120.95 (-1.02%)
ICICI Bank 709.55 (-0.94%)
IndusInd Bank 915.65 (-3.73%)
Infosys 1695.30 (-2.32%)
ITC 217.90 (-1.69%)
JSW Steel 642.85 (-0.26%)
Kotak Mah. Bank 1885.20 (-1.51%)
Larsen & Toubro 1782.65 (-1.03%)
M & M 822.15 (-1.77%)
Maruti Suzuki 7042.85 (-2.30%)
Nestle India 19016.50 (-1.58%)
NTPC 124.35 (-2.09%)
O N G C 143.35 (-1.75%)
Power Grid Corpn 202.00 (-1.99%)
Reliance Industr 2362.60 (-1.90%)
SBI Life Insuran 1148.50 (-1.50%)
Shree Cement 25612.35 (-1.16%)
St Bk of India 465.30 (-1.66%)
Sun Pharma.Inds. 737.15 (-1.95%)
Tata Consumer 747.60 (-3.45%)
Tata Motors 467.20 (-2.69%)
Tata Steel 1108.80 (-0.82%)
TCS 3536.40 (-2.86%)
Tech Mahindra 1551.75 (-2.61%)
Titan Company 2325.30 (-1.86%)
UltraTech Cem. 7214.60 (-1.61%)
UPL 716.55 (0.53%)
Wipro 624.50 (-2.54%)
INDSWFTLAB

Ind-Swift Laboratories Lt..

₹72.25
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

  • Master Rating:
  • Ind-Swift Labs. (Nse) has an operating revenue of Rs. 938.25 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 2% needs improvement, ROE of -0% is poor and needs improvement. The company has a high debt to equity of 146%, which can be a reason to worry. The stock from a technical standpoint is trading below to its 200DMA and around 8% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

As per analysts rating in the last 6 months, the recommendation isHOLD Ind-Swift Labs.

Ind-Swift Laboratories Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Ind-Swift Laboratories Ltd Synopsis

NSE-Medical-Generic Drugs

Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 856.58 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2021. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
  • Market Cap

    INR 426.02 Cr

  • Sales

    INR 903.50 Cr

  • Shares in Float

    3.43 Cr

  • No of Funds

    5 K

  • Yield

    %

  • Book Value

    0.68

  • U/D Vol Ratio

    1.2

  • LTDebt/Equity

    137%

  • Alpha

    0.04

  • Beta

    0.77

Ind-Swift Laboratories Ltd Ownership
Ind-Swift Laboratories Ltd Management

Ind-Swift Laboratories Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 638.691644.6083590.2898543.372525.8829
Fixed Assets Annual Cr 769.3525854.3822933.33241002.61741112.4796
Total Non Current Assets Annual Cr 951.39441015.64021095.48511188.52491313.8177
Total Current Assets Annual Cr 865.8046844.5614817.2921808.5044807.4679
Total Assets Annual Cr 1817.1991860.20161912.77721997.02932121.2856
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 107.783122.243118.133115.683
ROE Annual % -4.95116.09-15.42
ROCE Annual % 5.664.345.463.32
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 23.7723.6723.7719.8818.12

Ind-Swift Laboratories Ltd Technicals

EMA & SMA

CURRENT PRICE

72.25 (-0.96)

    • Bullish Moving Averages 4
    • Bearish Moving Averages 12

EMA

  • 20 Day

    72.81

  • 50 Day

    71.15

  • 100 Day

    73.2

  • 200 Day

    80.15

Ind-Swift Laboratories Ltd Resistance and support

73.69 PIVOT

  • First Resistance

    74.77

  • Second Resistance

    76.59

  • Third Resistance

    77.67

  • First Support

    71.87

  • Second Support

    70.79

  • Third Support

    68.97

  • RSI

    50.66

  • MFI

    66.12

  • MACD

    1.71

  • MACD signal line

    2.2

Ind-Swift Laboratories Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 80,102 4,683,564 58.47%
Week 138,653 7,605,128 54.85%
1 Month 253,525 15,563,909 61.39%
6 Month 612,871 25,182,887 41.09%

Ind-Swift Laboratories Ltd Price change analysis

-4.8

Over 1 month

Low High
68 83

3.85

Over 3 month

Low High
55.15 83

-13.8

Over 6 months

Low High
55.15 127.45

6.95

Over Year

Low High
55.15 127.45

Similar Stocks

News

IND-SWIFT LABORATORIES LTD. - 532305 - Compliances-Reg. 57 (

Intimation under Regulation 57 of SEBI (LODR), 2015 for the month of November 2021. Read More

Ind-Swift Laboratories Ltd - 532305 - Announcement under Reg

COPY OF NEWSPAPER PUBLICATION OF UN-AUDITED FINANCIAL RESULTS Read More

IND-SWIFT LABORATORIES LTD. - 532305 - Updates On Business T

Updates on Business Transfer Agreement Read More

IND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Outcome

Outcome of Board Meeting Read More

IND-SWIFT LABORATORIES LTD. - 532305 - Unaudited Financial R

Unaudited Financial Results for the Quarter and Half Year ended 30.09.2021 Read More

Blogs

FAQs

Stock Directory-

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All 0-9